Research & Development: Page 36
-
PharmaVoice Team/PharmaVoice
The Year Ahead…
We ask more than 130 experts, what needs to happen to address inefficiency and productivity to achieve aspirational goals for healthcare in the future. For this year’s special 2020 Year in Preview issue, we posed 20 provocative questions to our community of thought leaders, who represent all aspe...
By Taren Grom • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Dr. Robot
Robots and docs — automation and clinician. In Disney’s animated hit Big Hero 6, we got a glimpse of what a future of a robot-enabled healthcare future might look like. Disney’s Baymax is an inflatable robot whose sole purpose is to take care of people in everyday life. But real-life medical robo...
By Taren Grom • Nov. 19, 2019 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Bringing Humanity Back to Healthcare
Technology can seem impersonal, but it can also be the driver for enabling more personal connections with patients. From the development of medicines by pharma companies to advancements in treatment protocols to using data to better apply therapeutic regimens, the healthcare industry is committed...
By Kim Ribbink • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Creating a Culture of Innovation
To create a culture of innovation, pharma companies will need to encourage different ways of thinking. By definition, innovation is “a new idea, creative thoughts, new imaginations in form of device or method." Innovation is also viewed as the application of better solutions that meet new require...
By Taren Grom • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Detecting cancer early is the key to defeating it. Laboratory for Advanced Medicine (LAM) is working to detect cancer in its infancy when treatment options have the best chance to be successful. The company’s platform technology, IvyGene, detects the presence of cancer in blood samples and gives ...
By PharmaVoice Team • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
HealthTech
First Patient Begins CVS Trial With Home Dialysis Machine Trend Watch: Telehealth Developments: At-home dialysis; skin patches for melanoma treatment; sweat monitoring, and norovirus detection. In August, the first patient involved in a clinical trial for a new CVS-funded home hemodialysis machin...
By PharmaVoice Team • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
MIT Model Predicts Cognitive Decline Due to Alzheimer’s Trend Watch: From Precision Medicine to Precision Diagnosis, AI Provides More Exact Approach A new model developed at MIT can help predict if patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline d...
By PharmaVoice Team • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Last Word
Transitioning Emerging Companies into Commercial Powerhouses Ronald Andrews, President and CEO of OncoCyte and a serial entrepreneur with nearly 30 years of experience, shares lessons for fostering the growth of development-stage companies. PV: You joined OncoCyte as president and CEO in July 201...
By Ronald Andrews • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Pharma's Future in Virtual Healthcare
With virtual health transforming the entire healthcare landscape, pharma is leveraging digital health tools to improve its processes. As healthcare is swept up in the extensive development of health management apps, telemedicine platforms, AI diagnosis, and the use of video, mobile apps, text mes...
By Robin Robinson • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Artificial Intelligence: Artificial Intelligence Gains Ground Across Healthcare
Adoption of artificial intelligence is accelerating across the healthcare industry. According to a survey of 50 executives at healthcare companies currently using AI, half believe AI will be broadly adopted across the industry by 2025. However, nearly half of U.S. companies say there is a need fo...
By PharmaVoice Team • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
The Role of AI in Helping Clinicians Diagnose Patients
I once thought I had multiple sclerosis. Actually, I may still have multiple sclerosis. I really don’t know for sure. A few months ago, a series of MS disease-awareness pop-ups began showing up on my web browser. They captured my attention because for a while I’d been experiencing a mix of health...
By Susan Abedi • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Staying Ahead of the AI Curve in Commercial Pharma
The commercial model within life sciences is ripe for change. In a landscape with harder to reach healthcare providers (HCPs) who are faced with more marketing noise than ever, the need for improved engagement is significant. According to DRG Digital, only 12% of HCPs said they had emailed with t...
By Matthew Van Wingerden • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
The Role Artificial Intelligence Plays in Humanizing the Health Experience
It used to be a broad, one-size-fits-all remedy for common complaints. If you needed it, there was little choice in what kind you received. If you didn’t need it, someone was ready to convince you otherwise. Fine-tuning it for an individual need was so cost-prohibitive the idea was basically scie...
By David Geisinger • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Transforming Clinical Development with AI
Applications in Imaging and Performance Risk Management The pharmaceutical industry and regulators alike have acknowledged for some time that the clinical development process is in need of an overhaul. Companies must find a way to innovate more efficiently to meet market demands and remain compet...
By Chris Porter • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
AI and Healthcare: From Potential to Powerful Solutions
In recent years, healthcare and pharma companies have been increasingly investing in the promise of artificial intelligence (AI), machine learning (ML), and other smart technologies. It’s estimated that the global market for AI healthcare will grow to as much as $27.6 billion by 2025.1 This growt...
By Dr. Harietta Eleftherochorinou • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Microbes As Therapies
While microbiome research is still in its infancy, interest and investment in this field of research has grown quickly. Efforts are ongoing to study how changes in the human microbiome can impact our health. Trillions of microbes — including bacteria, fungi, and viruses — call us home. These bact...
By Denise Myshko • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
The Blockchain Movement
The pharmaceutical industry is actively exploring blockchain technology — a digital ledger system for records and log transactions — for a number of uses. Experts discuss applications for the industry. Blockchain, the underlying technology behind bitcoin and other cryptocurrencies, is being explo...
By Denise Myshko • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
The Intersection of Physics and Biology Daniel O’Connor, President and CEO of OncoSec, talks about his company’s efforts to develop new technologies to stimulate the body’s immune system to target and attack cancer. It is estimated that there are 1.6 million new cases of solid tumor cancers in th...
By Daniel O'Connor • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
HealthTech
New Microscope Reveals Interactions Between Drugs and Receptors Trend Watch: Advances in Healthtech Benefit Oncology, Military Docs, Patients, Drug Delivery, and More Researchers at Case Western Reserve University School of Medicine have used a cryo-electron microscopy technique to observe the in...
By PharmaVoice Team • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Using AI to Connect Patients To Clinical Trials Trend Watch: AI Advances: From Nutrition Advice to Digital Pathology Ohio-based Deep Lens has developed an AI-enabled digital pathology platform that connects to trusted networks of pharma sponsors, researchers, and care teams, so patients can be ma...
By PharmaVoice Team • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
Last Word
Improving Clinical Trials Through Conversations Suzann Johnson, Associate Director of Investigator and Patient Engagement at Janssen, talks about how the company’s HealthCaring Conversations for Clinical Research initiative can improve the clinical trial experience for patients and investigators....
By Suzann Johnson • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Big Data: Realizing Big Impacts from Investing in Big Data
The pharmaceutical industry is investing more and more in big data to transform different parts of the business and bolster pipelines. Investment in big data is expected to grow to $7 billion by the end of 2021, up from $4.7 billion in 2018, comprising spending on hardware, software, and professi...
By PharmaVoice Team • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
Why Patients Avoid Clinical Trials
And how big data, analytics, technology and domain expertise can help change the paradigm The pharma industry has a big challenge when it comes to clinical trials, one that continues to hinder the industry’s approach to research. Sponsors want patients to enroll in their trials, but the clinical ...
By Cynthia Verst • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
A Framework for Harnessing Big Data in Creative Ideation
We propose a five-part framework for marketers and advertisers looking to harness the potential of data and creativity in healthcare communications in this era of big data and artificial intelligence. Data and Creativity Big data and its related components, such as AI and deep learning, are big t...
By Iyiola Obayomi • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
No Longer Lost in Translation
Biopharma companies, academia, patient groups, and the NIH are embracing translational medicine to increase the number of drugs that can be successfully brought to market. The current process of translating a new discovery into a therapy is slow and expensive. The average length of time from disc...
By Denise Myshko • Sept. 1, 2019
Previous
